Are Shareholders Getting Enough in the Cypress Semiconductor Buyout?
Cypress Semiconductor shares hit a multiyear high on Monday after the firm announced that it would be acquired by Infineon.
All Work
Chris Lange
Why Genocea’s Neoantigen Treatment Is Such a Big Hit at ASCO
Here is why Genocea Biosciences is one of the big winners from the annual meeting of the American Society of Clinical Oncology (ASCO).
Can Amazon Deliver 10 Million Items in One Day?
Amazon.com is in the midst of upgrading its Prime membership, and that means now roughly 10 million items qualify for one-day delivery.
Why NABE Thinks a Recession Is Off the Menu in 2019
The National Association for Business Economics released its survey for the month of May, and despite overarching concerns about recession and trade wars the panel saw a favorable outlook in the short term.
Beyond Meat, Campbell Soup, GameStop, Salesforce and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Beyond Meat, GameStop, Salesforce and some of the other most anticipated earnings reports expected this week.
Fox Bets Big on Stars Group Partnership
Stars Group is pursuing a new partnership that includes joint development of a sports-gambling app with Fox Branding. Stars and Fox essentially signed a 25-year deal in which they expect to launch two apps…
Slack Closes in on IPO
Collaboration tools and services provider Slack Technologies has amended its filing with the SEC for its initial public offering.
Meet One of ASCO’s First Losers
Turning Point Therapeutics shares dipped on Friday after the firm posted interim data for its midstage study in ROS1-positive non-small cell lung cancer patients.
Can Nutanix Turn Itself Around After This Dismal Q3 Report?
Nutanix shares tumbled after it released its most recent quarterly results and offered disappointing guidance.
Uber vs Lyft: Who Won the First Round of Ride-Share Earnings?
Uber reported its first quarter financial results Thursday after the markets closed.
Should Costco Get More Credit for Its Q2 Earnings?
Costco Wholesale rose marginally early Friday even though it reported better than expected quarterly results late on Thursday.
Why Cara Therapeutics Could Rise Another 50%
Cara Therapeutics recently announced data from its late-stage trial in patients with chronic kidney disease. While there was a very positive reaction among investors, one analyst believes that this stock could soar even higher.
Is. J.Jill Facing Existential Threat With Other Womens Retailers?
J.Jill shares were absolutely crushed on Thursday morning after the company reported its fiscal first-quarter financial results.
Dollar General or Dollar Tree: Who Had the Better Q1 Report?
Dollar General and Dollar Tree each released its fiscal first-quarter financial results before the markets opened on Thursday. The question is which retailer had the better report?
AstraZeneca Cuts Almost All Ties to Inovio Pharma
Inovio Pharmaceuticals shares dipped on Wednesday after it was announced that the firm’s partnership with AstraZeneca would be scaled back.
What to Expect When Dollar General Reports Thursday
Dollar General is scheduled to release its fiscal first quarter financial results before the markets open on Thursday. The consensus estimates are calling for $1.39 in earnings per share (EPS) and $6.56 billion in…
Bed Bath & Beyond Succumbs to Activists
Bed Bath & Beyond is in the midst of transformational changes to the organization. Now, the retailer is making some big changes at the top — in its board of directors.
AMC Entertainment’s Unbelievable Membership Growth
AMC Entertainment has seen incredible success over the past few years in its loyalty program. Despite this announcement, shares were pulled down by market headwinds on Wednesday.
What This Cara Therapeutics Late-Stage Study Could Mean for Chronic Kidney Disease
Cara shares jumped on Wednesday after the firm announced topline data from its late-stage trial in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus.
Abercrombie & Fitch Squashes Its Own Turnaround
Abercrombie & Fitch released disappointing fiscal first-quarter financial results before the markets opened on Wednesday.